Kimberly Banks MacKay's most recent trade in West Pharmaceutical Services, Inc. was a trade of 1,162 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| West Pharma Services | Kimberly Banks MacKay | SVP, GC & Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 1,162 | 1,162 | - | - | Stock Option (Right to Buy) | |
| West Pharma Services | Kimberly Banks MacKay | SVP, GC & Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 503 | 503 | - | - | Rst. Stock Unit | |
| West Pharma Services | Kimberly Banks MacKay | SVP, GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 211.14 per share. | 18 Feb 2025 | 246 | 1,604 (0%) | 0% | 211.1 | 51,940 | Common Stock |
| West Pharma Services | Kimberly Banks MacKay | SVP, GC & Corporate Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 212.59 per share. | 18 Feb 2025 | 92 | 1,511 (0%) | 0% | 212.6 | 19,558 | Common Stock |
| West Pharma Services | MacKay Kimberly Banks | SVP, GC & Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 2,411 | 2,411 | - | - | Stock Options (Right to Buy) | |
| West Pharma Services | Banks MacKay Kimberly | SVP, GC & Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 720 | 1,358 (0%) | 0% | 0 | Common Stock | |
| West Pharma Services | Kimberly Banks MacKay | SVP, GC & Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 2,988 | 2,988 | - | - | Stock Options (Right to buy) | |
| West Pharma Services | Kimberly Banks MacKay | SVP, GC & Corporate Secretary | Grant, award, or other acquisition of securities at price $ 306.68 per share. | 21 Feb 2023 | 327 | 637 (0%) | 0% | 306.7 | 100,284 | Common Stock |
| West Pharma Services | Kimberly Banks MacKay | SVP, GC & Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 3,108 | 3,108 | - | - | Stock Options (Right to buy) | |
| West Pharma Services | Kimberly Banks MacKay | SVP, GC & Corporate Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 369.13 per share. | 22 Feb 2022 | 310 | 310 (0%) | 0% | 369.1 | 114,430 | Common Stock |
| West Pharma Services | Kimberly Banks MacKay | SVP, GC & Corporate Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 4,364 | 4,364 | - | - | Stock Options (Right to buy) |